For Charu Aggarwal, MD, of the Abramson Cancer Center, immunotherapy is now the fourth element in the armamentarium for cancer treatment. In this video, Dr. Aggarwal examines recent advances in immunotherapy for patients with lung cancer, with a focus on the efficacy and safety of the PD-1 checkpoint inhibitors, vaccines, monoclonal antibodies, CAR-T cell therapy and combination chemotherapy/immunotherapy treatments.

Related Links:
ReachMD: Adjuvant Therapies for Lung Cancer
Dr Aggarwal’s Profile